Effects of Intravenous Magnesium Sulfate on Calcium-Regulating Hormones, Plasma and Urinary Electrolytes in Healthy Horses

Abstract

Intravenous magnesium sulfate (MgSO 4 ) is used in equine practice to treat hypomagnesemia, dysrhythmias, neurological disorders, and calcium dysregulation. MgSO 4 is also used as a calming agent in equestrian events. Hypercalcemia affects calcium-regulating hormones, as well as plasma and urinary electrolytes; however, the effect of hypermagnesemia on these variables is unknown. The goal of this study was to investigate the effect of hypermagnesemia on blood parathyroid hormone (PTH), calcitonin (CT), ionized calcium (Ca 2+ ), ionized magnesium (Mg 2+ ), sodium (Na + ), potassium (K + ), chloride (Cl - ) and their urinary fractional excretion (F) after intravenous administration of MgSO 4 in healthy horses. Twelve healthy female horses of 4-18 years of age and 432-600 kg of body weight received a single intravenous dose of MgSO 4 (60 mg/kg) over 5 minutes, and blood and urine samples were collected at different time points over 360 minutes. Plasma Mg 2+ concentrations increased 3.7-fold over baseline values at 5 minutes and remained elevated for 120 minutes (P < 0.05), Ca 2+ concentrations decreased from 30-60 minutes (P < 0.05), but Na + , K + and Cl - concentrations did not change. Serum PTH concentrations dropped initially to rebound and remain elevated from 30 to 60 minutes, while CT concentrations increased at 5 minutes to return to baseline by 10 minutes (P < 0.05). The FMg, FCa, FNa, FK, and FCl increased, while urine osmolality decreased from 30-60 minutes compared baseline (P < 0.05). Experimental hypermagnesemia alters calcium-regulating hormones (PTH, CT), reduces plasma Ca 2+ concentrations, and increases the urinary excretion of Mg 2+ , Ca 2+ , K + , Na + and Cl - in healthy horses. This information has clinical implications on the short-term effects of hypermagnesemia on calcium-regulating hormones as well as plasma and urine electrolytes.